Epidural Versus Low-dose Spinal for Analgesia of Late First Stage of Labor
1 other identifier
interventional
100
1 country
1
Brief Summary
The aim of this study is to compare the effect of epidural analgesia versus low-dose spinal analgesia in parturient in the late first stage of labor regarding time needed to perform the block, duration of the intra- and postoperative analgesia and incidence of procedure related adverse events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 14, 2021
CompletedFirst Submitted
Initial submission to the registry
September 15, 2021
CompletedFirst Posted
Study publicly available on registry
September 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedDecember 7, 2022
December 1, 2022
1 year
September 15, 2021
December 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
The time to perform the block
The time from the preparation of the block until the full injection of anesthetic drugs,
Intraoperative
Secondary Outcomes (3)
Mean arterial blood pressure (MAP)
Intraoperative
Heart rate (HR)
Intraoperative
Number of participnts with Postoperative nausea and vomiting (PONV)
First 24 hours postoperatively
Study Arms (2)
Epidural Anesthesia
ACTIVE COMPARATORPatients will receive epidural analgesia with 15 ml isobaric bupivacaine 0.125% plus fentanyl 2 μg/mL
Spinal Anesthesia
ACTIVE COMPARATORPatients will receive Spinal analgesia with 5 mg bupivacaine and 25 μg of fentanyl in a 2 ml volume.
Interventions
Patients will receive epidural analgesia with 15 ml isobaric bupivacaine 0.125% plus fentanyl 2 μg/mL.
Patients will receive Spinal analgesia with 5 mg bupivacaine and 25 μg of fentanyl in a 2 ml volume.
Eligibility Criteria
You may qualify if:
- Parturient with normal vaginal delivery in late first stage of labor (cervical dilatation ≥ 6 cm by examination)
- Aged 18-40 years old
- Single, term pregnant with normal fetal heart rate
- Request neuroaxial analgesia
You may not qualify if:
- Parturient who refuses to participate,
- American Society of Anesthesiologists (ASA) physical status \>II,
- Body mass index more than 35 kg/m2
- Severe pre-eclampsia or eclampsia
- Uncontrolled thyrotoxicosis
- Cardiovascular troubles (e.g. stenotic valvular heart disease or cardiomyopathy)
- Increased intracranial tension due to a space-occupying lesion
- Any contraindication to regional anesthesia such as local skin or soft tissue infection, coagulopathy or receiving anticoagulant therapy, thrombocytopenic, uncorrected hypovolemia, preexisting neurologic deficits, spinal deformity or previous spine surgery.
- Hypersensitivity to the study drugs
- Parturient who scheduled for emergency cesarean section due to fetal distress, antepartum hemorrhage, multiple gestation or fetal malpresentation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University Hospitals
Cairo, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 15, 2021
First Posted
September 24, 2021
Study Start
September 14, 2021
Primary Completion
October 1, 2022
Study Completion
October 1, 2022
Last Updated
December 7, 2022
Record last verified: 2022-12